|
ARPC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.024900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.548080E-02 |
| Normal-vs-Stage2 |
1.322570E-01 |
| Normal-vs-Stage3 |
4.684300E-02 |
| Normal-vs-Stage4 |
2.402900E-03 |
| Stage1-vs-Stage2 |
7.384600E-01 |
| Stage1-vs-Stage3 |
9.963200E-01 |
| Stage1-vs-Stage4 |
1.267600E-01 |
| Stage2-vs-Stage3 |
7.824000E-01 |
| Stage2-vs-Stage4 |
1.713750E-01 |
| Stage3-vs-Stage4 |
1.683830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.344600E-03 |
| Normal-vs-AfricanAmerican |
5.578400E-01 |
| Normal-vs-Asian |
5.082000E-02 |
| Caucasian-vs-AfricanAmerican |
8.291600E-02 |
| Caucasian-vs-Asian |
3.744800E-01 |
| AfricanAmerican-vs-Asian |
1.790200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.794000E-02 |
| Normal-vs-Female |
6.381500E-03 |
| Male-vs-Female |
6.256200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.030040E-01 |
| Normal-vs-Age(41-60Yrs) |
8.236100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.351760E-02 |
| Normal-vs-Age(81-100Yrs) |
7.877000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.289400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.142800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.332800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.832800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.842150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.181200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.010400E-01 |
| Normal-vs-Grade 2 |
5.242900E-03 |
| Normal-vs-Grade 3 |
5.834400E-02 |
| Normal-vs-Grade 4 |
9.830800E-04 |
| Grade 1-vs-Grade 2 |
9.224600E-01 |
| Grade 1-vs-Grade 3 |
7.312600E-01 |
| Grade 1-vs-Grade 4 |
1.813190E-01 |
| Grade 2-vs-Grade 3 |
3.607400E-01 |
| Grade 2-vs-Grade 4 |
9.342300E-02 |
| Grade 3-vs-Grade 4 |
3.321700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.180370E-02 |
| Normal-vs-ccB subtype |
2.300600E-03 |
| ccA subtype-vs-ccB subtype |
1.401830E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.935000E-03 |
| Normal-vs-N1 |
1.111560E-02 |
| N0-vs-N1 |
6.759800E-02 |
|
|
